Abstract
The aim of this study was to investigate the effects of intra-articular hyaluronic acid (HA) on symptoms, functional outcome, and changes in articular cartilage assessed by magnetic resonance imaging (MRI) in patients with knee osteoarthritis. Thirty patients were randomly assigned to treatment with HA (hylan G-F 20, Synvisc) or saline. The treatment group consisted of 20 patients receiving three weekly injections of HA into one or both knees (30 knees). The control group consisted of ten patients receiving three intra-articular injections of 2 ml saline at the same intervals (ten knees). To determine the effectiveness of the HA therapy, all patients were assessed prior to the injections (baseline) and after the 1st, 2nd, 3rd, and 8th weeks. Assessment comprised the following: pain at rest, at night, and on walking using a visual analogue scale (VAS); Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain, stiffness, and function scores; 15-m walking time; need for analgesics; and evaluation of treatment by the patients. MRI of patellofemoral (PF) articular cartilage was also examined before and after the course of injections at the 8th week. When compared to placebo, a significant statistical difference was found in all clinical parameters. On MRI, although the difference in the PF joint cartilage quality in the HA group before and after the treatment was statistically significant (p<0.05), this significance was not detected between the groups after the treatment (p>0.05). After the HA injections, a significant analgesic effect was seen as early as the 3rd week continuing up to the 8th week and functional improvement was seen at the 8th week. In conclusion, intra-articular injections of HA is an effective choice of treatment in patients with knee osteoarthritis.
This is a preview of subscription content,
to check access.

Similar content being viewed by others
References
American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (2000) Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 43:1905–1925
Scott JC, Lethbridge C, Hochberg MC (1999) Epidemiology and economic consequences of osteoarthritis. Osteoarthritis clinical and experimental aspects. Springer, Berlin Heidelberg New York, pp 20–38
Pelletier JP, Pelletier MJ (1993) The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol Suppl 39:19–24
Goorman SD, Watanabe TK, Miller EH, Perry C (2000) Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study. Arch Phys Med Rehab 81:479–483
Kirwan J (2001) Is there a place for intra-articular hyaluronate in osteoarthritis of the knee? Knee 8:93–101
Simon LS (1999) Viscosupplementation therapy with intraarticular hyaluronic acid. Fact or fantasy? Rheum Dis Clin North Am 25:345–357
Weiss C, Band P (1999) Basic principles underlying the development of viscosupplementation for the treatment of osteoarthritis. J Clin Rheumatol 5:2–11
Wobig M (1999) Hylan G-F 20 (Synvisc) for the treatment of osteoarthritis of the knee. Clinical studies and practical considerations. J Clin Rheumatol 5:12–17
Peyron JG (1993) Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol Suppl 39:10–15
Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis of the knee. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049
Kellgren HJ, Lawrence SJ (1967) Radiological assessment of osteoarthritis. Ann Rheum Dis 16:494–501
Chan WP, Lang P, Stevens MP, Sack K, Majumdar S, Basch C, Genant HK (1991) Osteoarthritis of the knee: comparison of radiography, CT and MR imaging to assess extent and severity. AJR Am J Roentgenol 157:799–806
Recht MP, Kramer J, Marcelis S, Pathria MN, Trudel D, Haghighi P, Sartoris DJ, Resnick D (1993) Abnormalities of articular cartilage in the knee: analysis of available MR techniques. Radiology 187:473–478
Bellamy N, Buchanan WW, Goldsmith C, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840
Watterson JR, Esdaile JM (2000) Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg 8:277–284
Shah R, Ericksen J, Lacerte M (2003) New frontiers: invasive nonsurgical interventions. Arch Phys Med Rehabil 84:39–44
Grecomoro G, Martorana U, Di Marco C (1987) Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 5:137–141
Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G et al (1999) The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 21:1549–1562
Lussier A, Alfred A, Charles A (1996) Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 23:1579–1585
Namiki O, Koyoshima H, Morisaki N (1982) Therapeutic effect of intraarticular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol 20:501–507
Carabba M, Paresce E, Angelini M et al (1992) The intra-articular treatment of osteoarthritis of the knee. A comparative study between hyaluronic acid (Hyalgan®) and orgotein. Eur J Rheumatol Inflamm 12:47–57
George E (1998) Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 57:637–640
Pietrogrande V, Melanotte P, D’Agnolo B (1991) Hyaluronic acid versus methylprednisolone intraarticularly injected for treatment of osteoarthritis of the knee. Curr Ther Res 50:691–701
Leardini G, Mattara L, Fracechini M, Perbelli A (1991) Intra-articular treatment of knee osteoarthritis: acomparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clin Exp Rheumatol 9:375–381
Adams E, Atkinson MH, Lussier A, Schulz JI, Siminovitch A, Wade JP, Zummer M (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee. Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 3:213–226
Kolarz G, Kotz R, Bröll H (1995) Hyaluronic acid in the comparative clinical study. Eur J Rheumatol Inflamm 15:39–45
Carabba M, Paresce E, Angelini M (1995) The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 15:25–31
Creamer P, Sharif M, George E, Meadows K, Cushnaghan J (1994) Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage 2:133–140
Guermazi A, Zaim S, Taouli B, Miaux Y, Peterfy CG, Genant HK (2003) MR findings in knee osteoarthritis. Eur Radiol 13:1370–1386
Gandy SJ, Dieppe PA, Keen MC, Maciewicz RA (2002) No loss of cartilage volume over three years in patients with knee osteoarthritis as assessed by magnetic resonance imaging. Osteoarthritis Cartilage 10:929–937
Gold GE, McCauley TR, Gray ML, Disler DG (2003) What’s new in cartilage? Radiographics 23:1227–1242
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Çubukçu, D., Ardıç, F., Karabulut, N. et al. Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol 24, 336–341 (2005). https://doi.org/10.1007/s10067-004-1043-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-004-1043-z